Thomas Ramdahl
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Dr. Thomas Ramdahl is a Chairman at Appsens AS and a Chairman at Precirix NV.
He is on the Board of Directors at Thor Medical ASA and Clarity Pharmaceuticals Ltd. Dr. Ramdahl was previously employed as a Non-Executive Director by Nordic Nanovector ASA, a President & Managing Director by Algeta ASA, a Senior Vice President-Operations by Pronova Biocare AB, a Chief Executive Officer by Bayer AS, and a Principal by Norsk Hydro ASA. He also served on the board at Golden Omega Norway AS.
He received his graduate degree from Norwegian University of Science & Technology and a doctorate degree from the University of Oslo.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 720.000 ( 0,19 % ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Direktor/Vorstandsmitglied | 01.03.2019 |
| THOR MEDICAL | Direktor/Vorstandsmitglied | 24.04.2025 |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Vorsitzender | - |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Develops, manufactures and distributes heart sensor | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| THOR MEDICAL | Direktor/Vorstandsmitglied | 03.01.2023 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Geschäftsführer | 01.01.2001 |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Vorstandsvorsitzender | - |
| NORSK HYDRO ASA | Corporate Officer/Principal | - |
Omegatri AS
Omegatri AS Food: Specialty/CandyConsumer Non-Durables Develops tablets and powders containing Omega-3 for the health and food industry | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Norsk Hydro ASA
Norsk Hydro ASA AluminumNon-Energy Minerals Engages in extrusion manufacturing, metal sales, bauxite mining and alumina & aluminum production and energy trading businesses | Non-Energy Minerals |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norwegian University of Science & Technology
Norwegian University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Omegatri AS
Omegatri AS Food: Specialty/CandyConsumer Non-Durables Develops tablets and powders containing Omega-3 for the health and food industry | Consumer Non-Durables |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Health Technology |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Develops, manufactures and distributes heart sensor | Health Technology |
Thor Medical ASA
Thor Medical ASA Miscellaneous Commercial ServicesCommercial Services Produces and supplies alpha particle emitters for cancer therapy | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen